## Why NAD+ Is the Molecule Everyone Should Know About
NAD+ (nicotinamide adenine dinucleotide) sits at the center of cellular energy metabolism. Every mitochondrion in every cell of your body depends on NAD+ to run the electron transport chain — the process that converts food into ATP.
Beyond energy production, NAD+ is the substrate for sirtuins (SIRT1–7) — the longevity enzymes that repair DNA, regulate gene expression, and maintain mitochondrial quality. It's also required by PARP enzymes for DNA damage repair, and by CD38 for calcium signaling.
The problem: NAD+ levels fall roughly 50% between age 20 and 50. This decline is now understood as a root cause — not merely a consequence — of mitochondrial dysfunction, metabolic disease, and the biological hallmarks of aging.
Both NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are precursors that the body converts into NAD+. They're similar but not identical. The differences matter.
## The Pathway: How Both Reach NAD+
```
NR → NMN → NaAD → NAD+
```
NR (nicotinamide riboside) is converted to NMN by the enzyme NRK (nicotinamide riboside kinase), then NMN is converted to NAD+ by NMNAT enzymes.
NMN (nicotinamide mononucleotide) enters the pathway one step further along — it's converted directly to NAD+ by NMNAT, bypassing the NRK step.
This seems to give NMN an advantage — fewer conversion steps. But the biology is more nuanced.
## The Absorption Debate
### The Original Argument for NR
Early research argued that NMN was too large to enter cells directly and had to be dephosphorylated to NR before crossing the cell membrane — meaning NMN and NR effectively arrived at the same place anyway. Under this model, NR had an edge because it was smaller and more directly absorbable.
### The Discovery of the SLC12A8 Transporter
A 2019 study in *Nature Metabolism* (Grozio et al.) identified a specific NMN transporter — SLC12A8 — in intestinal cells that allows NMN to enter cells directly without conversion to NR first. This transporter is upregulated under conditions of low NAD+, suggesting the body has a dedicated mechanism for NMN absorption when it needs it most.
This finding reframed the debate. NMN may have a direct uptake route that NR lacks.
### Sublingual NMN
Subsequent research and anecdotal evidence from researchers including David Sinclair (Harvard) suggest that sublingual (under-tongue) NMN administration bypasses intestinal metabolism entirely, delivering NMN directly into the bloodstream. Several commercial NMN products now use sublingual delivery formats specifically for this reason.
## What Human Clinical Trials Actually Show
### NMN Human Evidence
- **2021 Keio University RCT** (*Nature Aging*): 250mg oral NMN daily for 12 weeks in healthy older men. Results: significant increase in NAD+ metabolites in blood and skeletal muscle, improved muscle insulin sensitivity, with no adverse effects.
- **2022 Washington University RCT** (*Science*): NMN supplementation improved muscle insulin sensitivity in prediabetic women, with increases in skeletal muscle NAD+ concentrations confirmed by biopsy.
### NR Human Evidence
- **2018 University of Colorado RCT** (*Nature Communications*): 500mg NR daily for 6 weeks in older adults increased blood NAD+ metabolites by ~60% and reduced aortic stiffness — a cardiovascular aging marker.
- **2020 Mayo Clinic RCT**: NR supplementation increased NAD+ in blood but did not significantly increase NAD+ in muscle or liver tissue — raising questions about tissue distribution.
### The Critical Distinction
NR appears to reliably raise blood NAD+ levels. NMN shows stronger evidence for raising NAD+ in target tissues — particularly skeletal muscle. Since mitochondrial function is the goal, muscle NAD+ matters more than blood NAD+.
## Dosing: What the Research Used
| Compound | Dose Used in Trials | Effective Range |
|---|---|---|
| NMN | 250–500mg/day | 250–1000mg/day |
| NR | 250–1000mg/day | 300–1000mg/day |
Both should be taken in the morning — NAD+ metabolism follows a circadian rhythm, and morning dosing aligns with the natural peak in NAMPT (the rate-limiting enzyme in NAD+ synthesis).
## Cost-Effectiveness
NMN is more expensive to produce than NR. At comparable doses:
- NR: ~$0.80–1.20/day at 500mg
- NMN: ~$1.50–2.50/day at 500mg (oral); sublingual formulations are pricier
The price gap has narrowed significantly as manufacturing scale has increased, particularly for Chinese-manufactured NMN.
## Which One Should You Take?
**Take NMN if:**
- You want the strongest evidence for muscle NAD+ and metabolic benefits
- You're willing to pay a modest premium
- You can use sublingual administration for improved bioavailability
- You're stacking with resveratrol or pterostilbene (which activate SIRT1, the NAD+-consuming longevity enzyme)
**Take NR if:**
- Budget is a primary consideration
- You prefer capsule form and have absorption concerns with NMN
- You're primarily targeting cardiovascular or general NAD+ restoration
**The honest answer:** Both work. The debate is at the margins. If you're taking either one consistently, you're ahead of the vast majority of people who take neither.
## The Resveratrol Stack
NAD+ precursors are most valuable when combined with sirtuin activators. Sirtuins consume NAD+ — so raising NAD+ without activating the enzymes that use it is like filling a gas tank without turning on the engine.
David Sinclair's reported personal protocol (shared in *Lifespan* and various podcasts):
- 1g NMN in the morning
- 1g resveratrol with yogurt (fat increases absorption)
- 1g metformin at night (prescription; not for everyone)
A more accessible starting point: 500mg NMN + 500mg trans-resveratrol or 100–150mg pterostilbene (more bioavailable resveratrol analog).
## What to Look for in an NMN Supplement
- **Purity certificate:** Third-party tested for >99% NMN purity
- **Form:** β-NMN (the biologically active form)
- **Packaging:** Dark glass or opaque capsules — NMN degrades with light and heat exposure
- **No unnecessary fillers:** Some cheap products pad with bulk agents that reduce effective dose
- **Sublingual for premium absorption:** Look for sublingual powder or tablet formats
## The Bottom Line
NAD+ decline is one of the most well-documented and mechanistically understood aspects of biological aging. Both NMN and NR address it through the same pathway, with NMN showing stronger tissue-level evidence in human trials.
At 500mg NMN per day in the morning — combined with exercise, time-restricted eating, and quality sleep — you're activating the same longevity pathways that endurance exercise and caloric restriction trigger, through a completely orthogonal mechanism.
The mitochondria notice the difference.
Written by
Mitoproof
Translating the science of cellular aging and biohacking into practical, evidence-grounded guidance for everyday protocols.




